Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

TEVA-TOLTERODINE LA 4 MG

TOLTERODINE TARTRATE : 4 MG · DIN 02412209 · TEVA CANADA LIMITED

Health Canada status: MARKETED

What is TEVA-TOLTERODINE LA?

TEVA-TOLTERODINE LA 4 MG contains TOLTERODINE TARTRATE : 4 MG. It is listed in the Health Canada Drug Product Database under DIN 02412209, held by TEVA CANADA LIMITED, supplied as CAPSULE (EXTENDED RELEASE) for ORAL administration. Health Canada currently lists it as marketed, status dated 16-Dec-2015. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is TEVA-TOLTERODINE LA used for?

TEVA-TOLTERODINE LA (tolterodine L-tartrate extended release capsules) is indicated for: the symptomatic management of patients with an overactive bladder with symptoms of urinary frequency, urgency, or urge incontinence, or any combination of these symptoms.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

DIN02412209
Brand nameTEVA-TOLTERODINE LA
Generic / active ingredientTOLTERODINE TARTRATE : 4 MG
ManufacturerTEVA CANADA LIMITED
Strength4 MG
Dosage formCAPSULE (EXTENDED RELEASE)
Route of administrationORAL
SchedulePrescription
ATC codeG04BD07 TOLTERODINE
BiosimilarNo
Health Canada statusMARKETED
Status date16-Dec-2015
Original market date2014-02-10 00:00:00

How is it stored and handled?

STORAGE AND STABILITY

How is it supplied?

null

What can be used instead?

Other Canadian products sharing ATC code G04BD07 TOLTERODINE. 14 of 26 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
DETROL1 MGTABLETBGP PHARMA ULCMARKETEDDIN 02239064
DETROL2 MGTABLETBGP PHARMA ULCMARKETEDDIN 02239065
DETROL LA2 MGCAPSULE (EXTENDED RELEASE)BGP PHARMA ULCMARKETEDDIN 02244612
DETROL LA4 MGCAPSULE (EXTENDED RELEASE)BGP PHARMA ULCMARKETEDDIN 02244613
JAMP TOLTERODINE1 MGTABLETJAMP PHARMA CORPORATIONMARKETEDDIN 02496836
JAMP TOLTERODINE2 MGTABLETJAMP PHARMA CORPORATIONMARKETEDDIN 02496844
MINT-TOLTERODINE1 MGTABLETMINT PHARMACEUTICALS INCMARKETEDDIN 02423308
MINT-TOLTERODINE2 MGTABLETMINT PHARMACEUTICALS INCMARKETEDDIN 02423316
SANDOZ TOLTERODINE LA2 MGCAPSULE (EXTENDED RELEASE)SANDOZ CANADA INCORPORATEDMARKETEDDIN 02413140
SANDOZ TOLTERODINE LA4 MGCAPSULE (EXTENDED RELEASE)SANDOZ CANADA INCORPORATEDMARKETEDDIN 02413159

Who else supplies TOLTERODINE worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. TOLTERODINE appears in 76 registered pack listings across 10 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for TEVA-TOLTERODINE LA

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for TEVA-TOLTERODINE LA

Health Canada Drug Product Database (DPD), DIN 02412209. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.